{"id":"https://openalex.org/W2154277743","doi":"https://doi.org/10.1111/j.1463-1326.2012.01634.x","title":"One\u2010year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment","display_name":"One\u2010year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-08","ids":{"openalex":"https://openalex.org/W2154277743","doi":"https://doi.org/10.1111/j.1463-1326.2012.01634.x","mag":"2154277743","pmid":"https://pubmed.ncbi.nlm.nih.gov/22690943"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2012.01634.x","doi":"https://doi.org/10.1111/j.1463-1326.2012.01634.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2012.01634.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2154277743"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068333266","display_name":"Wolfgang Kothny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"W. Kothny","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Q. Shao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Q. Shao","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025610737","display_name":"Per\u2010Henrik Groop","orcid":"https://orcid.org/0000-0003-4055-6954","observed_orcids":["https://orcid.org/0000-0003-4055-6954"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P.\u2010H. Groop","raw_affiliation_strings":["Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland","Folkh\u00e4 lsan Institute of Genetics Folkh\u00e4 lsan Research Center  Biomedicum Helsinki of Helsinki Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]},{"raw_affiliation_string":"Folkh\u00e4 lsan Institute of Genetics Folkh\u00e4 lsan Research Center  Biomedicum Helsinki of Helsinki Finland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019524426","display_name":"Valentina Lukashevich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Lukashevich","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5068333266"],"corresponding_institution_ids":["https://openalex.org/I4210117619"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":9.9585,"has_fulltext":false,"cited_by_count":111,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98799533,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"14","issue":"11","first_page":"1032","last_page":"1039"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9300000071525574},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9520000219345093},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6679999828338623},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9390000104904175},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6790000200271606},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7710000276565552},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.6710000038146973},{"id":"https://openalex.org/keywords/glomerular-filtration-rate","display_name":"glomerular filtration rate","score":0.7739999890327454},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.4259999990463257},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.5559999942779541},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.9708471298217773},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8463374972343445},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8269685506820679},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.801761269569397},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.704544186592102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6984429359436035},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6070641279220581},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5352241396903992},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.528439998626709},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.46163153648376465},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44772014021873474},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4356752634048462},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.20209231972694397},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077597","descriptor_name":"Vildagliptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2012.01634.x","doi":"https://doi.org/10.1111/j.1463-1326.2012.01634.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2012.01634.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:22690943","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22690943","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1970406523","https://openalex.org/W1983130067","https://openalex.org/W2018608782","https://openalex.org/W2028317115","https://openalex.org/W2055753691","https://openalex.org/W2058933537","https://openalex.org/W2064978103","https://openalex.org/W2074925580","https://openalex.org/W2075182875","https://openalex.org/W2079841945","https://openalex.org/W2081276121","https://openalex.org/W2097979726","https://openalex.org/W2100987099","https://openalex.org/W2109077746","https://openalex.org/W2117864471","https://openalex.org/W2165765596","https://openalex.org/W2169075937","https://openalex.org/W2171116761","https://openalex.org/W2414002317","https://openalex.org/W4250647894"],"related_works":["https://openalex.org/W2079841945","https://openalex.org/W2062321935","https://openalex.org/W603325110","https://openalex.org/W3029763447","https://openalex.org/W2041950907","https://openalex.org/W2014536426","https://openalex.org/W2100987099","https://openalex.org/W2001209027"],"abstract_inverted_index":{"AIM:":[0],"Assess":[1],"long-term":[2],"safety":[3,37,256],"and":[4,22,38,48,63,77,90,96,98,107,120,124,153,199,206,233,243],"efficacy":[5,39],"of":[6,40,113,173],"the":[7,111,131],"dipeptidlyl":[8],"peptidase-4":[9],"(DPP-4)":[10],"inhibitor":[11],"vildagliptin":[12,41,106,205,248],"in":[13,59,134,138,147,160,272],"369":[14],"patients":[15,60,92,100,114,167,174,214,240],"with":[16,61,93,101,110,168,204,215,241,279],"type":[17],"2":[18],"diabetes":[19],"mellitus":[20],"(T2DM)":[21],"moderate":[23,64,94,123,148,169,244],"or":[24,65,245],"severe":[25,66,102,125,161,216,246],"renal":[26],"impairment":[27],"(RI).":[28],"METHODS:":[29],"Double-blind,":[30],"randomized,":[31],"parallel-group,":[32],"52-week":[33],"clinical":[34],"trial":[35],"comparing":[36],"(50":[42],"mg":[43],"qd,":[44],"n":[45],"=":[46,51,145,151,164],"216)":[47],"placebo":[49,260],"(n":[50],"153)":[52],"added":[53,249],"to":[54,73,105,194,228,250,259,266],"ongoing":[55,251],"stable":[56],"antihyperglycaemic":[57],"treatment,":[58],"T2DM":[62,242],"(glomerular":[67],"filtration":[68],"rate":[69],"[GFR]":[70],"\u2265":[71],"30":[72,79],"<50":[74],"ml/min/1.73":[75,80],"m(2)":[76,81],"<":[78,158],")":[82],"RI.":[83],"RESULTS:":[84],"The":[85],"study":[86],"population":[87],"comprised":[88],"122":[89],"89":[91],"RI":[95,103,149,162],"94":[97],"64":[99],"randomized":[104],"placebo,":[108,207,267],"respectively,":[109],"majority":[112],"receiving":[115],"background":[116],"insulin":[117],"therapy":[118,253],"(72%":[119],"82%":[121],"for":[122,213],"RI,":[126,170,247],"respectively).":[127],"After":[128],"1":[129],"year,":[130],"between-treatment":[132],"difference":[133],"adjusted":[135],"mean":[136],"change":[137],"A1C":[139,273],"was":[140,210,274],"-0.4":[141],"\u00b1":[142,155],"0.2%":[143,156],"(p":[144,157],"0.005)":[146],"(baseline":[150,163],"7.8%)":[152],"-0.7":[154],"0.0001)":[159],"7.6%).":[165],"In":[166,239],"similar":[171,258],"proportions":[172],"experienced":[175],"any":[176,183,191],"adverse":[177,185],"event":[178,186],"(AE)":[179],"(84":[180],"vs.":[181,189,197,202,220,224,231,236],"85%),":[182],"serious":[184],"(SAE)":[187],"(21":[188],"19%),":[190],"AE":[192],"leading":[193,227],"discontinuation":[195,229],"(5%":[196],"6%)":[198,232],"death":[200,234],"(1%":[201],"0%)":[203],"respectively.":[208],"This":[209],"also":[211],"true":[212],"RI:":[217],"AEs":[218,226],"(85%":[219],"88%),":[221],"SAEs":[222],"(25%":[223],"25%),":[225],"(10%":[230],"(3%":[235],"2%).":[237],"CONCLUSIONS:":[238],"antidiabetic":[252],"had":[254],"a":[255,268],"profile":[257],"during":[261],"1-year":[262,277],"observation.":[263],"Furthermore,":[264],"relative":[265],"clinically":[269],"significant":[270],"decrease":[271],"maintained":[275],"throughout":[276],"treatment":[278],"vildagliptin.":[280]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2154277743","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
